Literature DB >> 7518797

Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation.

S D Mawhorter1, J W Kazura, W H Boom.   

Abstract

Human eosinophils become hypodense and express class II major histocompatibility (MHC) molecules when activated by granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro or in vivo in pathological conditions such as allergic disorders. In this study, we examined the capacity of class II MHC-expressing eosinophils to serve as antigen-presenting cells (APC) for resting and activated CD4+ T cells. Eosinophils were isolated from healthy donors and incubated in conditioned medium (CM) containing GM-CSF for 2-4 days, after which 15-92% of the cells expressed class II MHC (HLA-DR). Preincubated eosinophils induced resting T cells to proliferate in response to the staphylococcal superantigens, Staphylococcus enterotoxins A, B and E. Furthermore, superantigen-induced T-cell proliferation correlated with the proportion of eosinophils expressing class II MHC molecules. When eosinophils and macrophages were compared for their ability to act as accessory cells for superantigen-induced T-cell proliferation, macrophages were more efficient than eosinophils. Eosinophils were not effective APC for microbial antigens (Ag), which required processing. Proliferative responses to purified protein derivative, tetanus toxoid, or Brugia malayi antigen were observed in only three of nine studies. The three positive studies included activated CD4+ T cells, whereas no responses were observed with resting CD4+ T cells. Macrophages and mononuclear cells were effective APC for these Ag for both resting and activated CD4+ T cells. These data indicate that although class II MHC-expressing eosinophils can serve as APC, they are relatively inefficient for the activation of CD4+ T cells by Ag, which require processing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518797      PMCID: PMC1422364     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

Review 2.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

Authors:  D L Mueller; M K Jenkins; R H Schwartz
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  The eosinophil, eosinophilia, and eosinophil-related disorders. II. Eosinophil infiltration and function.

Authors:  T B Nutman; S G Cohen; E A Ottesen
Journal:  Allergy Proc       Date:  1988 Nov-Dec

4.  Mature human eosinophils have the capacity to express HLA-DR.

Authors:  D R Lucey; A Nicholson-Weller; P F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals.

Authors:  L Koenderman; P T Kok; M L Hamelink; A J Verhoeven; P L Bruijnzeel
Journal:  J Leukoc Biol       Date:  1988-08       Impact factor: 4.962

6.  Superantigens interact with MHC class II molecules outside of the antigen groove.

Authors:  P Dellabona; J Peccoud; J Kappler; P Marrack; C Benoist; D Mathis
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  Eosinophils cocultured with endothelial cells have increased survival and functional properties.

Authors:  M E Rothenberg; W F Owen; D S Silberstein; R J Soberman; K F Austen; R L Stevens
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

8.  Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.

Authors:  H G Fischer; S Frosch; K Reske; A B Reske-Kunz
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

9.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.

Authors:  C H June; J A Ledbetter; M M Gillespie; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

10.  Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells.

Authors:  R Carlsson; H Fischer; H O Sjögren
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

View more
  33 in total

Review 1.  Staphylococcus aureus superantigens and airway disease.

Authors:  Claus Bachert; Philippe Gevaert; Paul van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

2.  MHC Class II and CD9 in human eosinophils localize to detergent-resistant membrane microdomains.

Authors:  Praveen Akuthota; Rossana C N Melo; Lisa A Spencer; Peter F Weller
Journal:  Am J Respir Cell Mol Biol       Date:  2011-09-01       Impact factor: 6.914

Review 3.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

Review 4.  Eosinophils, ribonucleases and host defense: solving the puzzle.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 5.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

6.  Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.

Authors:  Margaret R Gyetko; Sudha Sud; Stephen W Chensue
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  The extracellular matrix protein mindin regulates trafficking of murine eosinophils into the airspace.

Authors:  Zhuowei Li; Stavros Garantziotis; Wei Jia; Erin N Potts; Sikander Lalani; Zhi Liu; You-Wen He; W Michael Foster; John W Hollingsworth
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

Review 8.  Eosinophils as antigen-presenting cells in allergic upper airway disease.

Authors:  Praveen Akuthota; Haibin Wang; Peter F Weller
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-02

9.  Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

Authors:  S Dubucquoi; A Janin; O Klein; P Desreumaux; P Quandalle; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

10.  Eosinophils and oral squamous cell carcinoma: a short review.

Authors:  C P Martinelli-Kläy; B R R N Mendis; T Lombardi
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.